Form 8-K - Current report:
SEC Accession No. 0001193125-22-113159
Filing Date
2022-04-21
Accepted
2022-04-21 17:04:01
Documents
12
Period of Report
2022-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d317850d8k.htm   iXBRL 8-K 23694
  Complete submission text file 0001193125-22-113159.txt   140916

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA neog-20220419.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220419_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220419_pre.xml EX-101.PRE 10811
6 EXTRACTED XBRL INSTANCE DOCUMENT d317850d8k_htm.xml XML 3256
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 22842210
SIC: 2835 In Vitro & In Vivo Diagnostic Substances